EVALUATION OF THE EFFECTIVENESS OF CHEMOTHERAPY DRUGS IN CERVICAL CANCER PATIENTS IN THE EDELWEISS INPATIENT ROOM RSUD ULIN BANJARMASIN
Keywords:
Effectiveness, Chemotherapy, Cervical cancerAbstract
Cervical cancer is cancer caused by infection with the Human Papilloma Virus (HPV) and one of the treatments is chemotherapy in combination with two or more drugs to increase the destruction of the number of cancer cells. This study aims to determine the patient characteristics, treatment patterns, doses, and evaluating the effectiveness of chemotherapy drugs in cervical cancer patients at the Edelweis Inpatient Installation of RSUD Ulin Banjarmasin. This research is descriptive quantitative research with a cross sectional method. Samples were taken by accidental sampling technique and the total samples were 31 samples. Data collection was carried out using patient medical records. The results of the study included: the characteristics of patients who underwent chemotherapy were at the age of 51-60 years (45.2%); the age at first marriage was mostly at the age of 15-20 years and married once (38.7%); the most stages were stage IIIB (41.9%); The treatment pattern used was a combination of Paclitaxel 230 mg and Carboplatin 450 mg. The effectiveness based on improvement in clinical symptoms in the form of the disappearance of vaginal discharge symptoms (26.9%) and vaginal bleeding symptoms (63%), as well as the decreased scores of pain rating scales. The results showed that chemotherapy was significant in lowering pain scores in cervical cancer patients (p<0.05).
References
Ambarwati, W. N., & Wardani, E. K. (2014). Adverse drug reactions (ADR) Kemoterapi Secara Fisik Pasien Penderita Kanker Servik. Prosiding Seminar Nasional & Internasional, 2(2), 97–106.
Dinas Kesehatan Provinsi. (2019). Jumlah Penderita Penyakit Kanker Leher Rahim. Banjarmasin: Dinkes, 1500.
FIGO. (2009). Revised FIGO Staging of the Vulva, Cervix, and Endometrium. International Journal of Gynecology & Obstetrics. Vol 105 (2), pp 103-104.
Globocan. (2020). Cancer Incident in Indonesia. International Agency for Research on Cancer, 858, 1–2.
Kitagawa, R., Katsumata, N., Shibata, T., Kamura, T., Kasamatsu, T., Nakanishi, T., Nishimura, S., Ushijima, K., Takano, M., Satoh, T., & Yoshikawa, H. (2015). Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(19), 2129–2135. https://doi.org/10.1200/JCO.2014.58.4391
Lantika, Y. F. O., Rusli, R., & Ayu, W. D. (2017). Kajian Pola Pengobatan Penderita Kanker Serviks Pada Pasien Rawat Inap Di Instalasi Rsud Abdul Wahab Sjahranie Periode 2014-2015. Jurnal Sains Dan Kesehatan, 1(8), 448–455. https://doi.org/10.25026/jsk.v1i8.89 (Diakses pada 09 September 2021).
Mariani, K. S. (2018). PROFIL PENGGUNAAN OBAT SITOSTATIKA PADA PASIEN KANKER RAWAT INAP YANG MENJALANI KEMOTERAPI DI RSUD PROF. Dr. W. Z. JOHANNES KUPANG TAHUN 2018.
Pangribowo, S. (2019). Beban Kanker di Indonesia. Pusat Data Dan Informasi Kementerian Kesehatan RI, 1–16.
Saleh, M., Virarkar, M., Javadi, S., Elsherif, S. B., de Castro Faria, S., & Bhosale, P. (2020). Cervical Cancer: 2018 Revised International Federation of Gynecology and Obstetrics Staging System and the Role of Imaging. AJR. American journal of roentgenology, 214(5), 1182–1195. https://doi.org/10.2214/AJR.19.21819
Shrivastava, S. B., Agrawal, G., Mittal, M., & Mishra, P. (2015). Management of Vaginal Cancer. Reviews on recent clinical trials, 10(4), 289–297. https://doi.org/10.2174/1574887110666150923112958
Susanti, E. (2017). GAMBARAN PENERIMAAN PASIEN AWAL TERDIAGNOSA KANKER SERVIKS DI POLI ONKOLOGI SATU ATAP (POSA) RSUD DR.SOETOMO SURABAYA.
Suwendar, Fudholi, A., Andayani, T. M., & Sastramihardja, H. S. (2016). Kemoterapi Berdasarkan Stadium. 1(2), 80–88.
Trijayanti, E. (2017). Hubungan Antara Asupan Makan dan Status Gizi Pada Pasien Kanker Serviks Post Kemoterapi. Journal of Chemical Information and Modeling, 53(9), 1689–1699.
Wipperman, J., Neil, T., & Williams, T. (2018). Cervical cancer: evaluation and management. American family physician, 97(7), 449-454.
Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020). Cervical cancer: Epidemiology, risk factors and screening. Chinese Journal of Cancer Research, 32(6), 720
